Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05103475 · ClinicalTrials.gov registry record · NA

Rage Against the Pain to Address Chronic Low Back Pain Among Veterans

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
36
Enrollment target

NCT05103475: Completed NA study, sponsored by VA Office of Research and Development.

NCT05103475 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05103475, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target

Study Summary

Chronic low back pain is a leading cause of disability among Veterans. Yoga is recommended as a front-line treatment option for chronic low back pain and is available across the VA healthcare system; however, despite yoga being the most widely adopted of VHA's Complementary and Integrative Health (CIH) therapies, Veteran participation in yoga still remains limited. Although it can be effective in managing pain, individuals cannot reap the benefits of yoga if they are unwilling to adopt it. One potential barrier to adoption of yoga among Veterans may be their perceptions of yoga, which for some, encompass long-held but perhaps inaccurate beliefs of what the practice entails and how their participation will be viewed by others. The goal of this study was to develop and evaluate an alternative-to-yoga program intended to improve Veteran participation and by extension, outcomes among Veterans with chronic low back pain. Based on Veteran input, we called this yoga program Rage Against the Pain (RAP) 'High Intensity Stretching'.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Rage Against the Pain (RAP)

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2022-08-15
Est. Completion 2023-10-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT05103475

The ClinicalTrials.gov registry entry for NCT05103475 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT05103475 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05103475 about?

NCT05103475 is a clinical study titled "Rage Against the Pain to Address Chronic Low Back Pain Among Veterans". Chronic low back pain is a leading cause of disability among Veterans. Yoga is recommended as a front-line treatment option for chronic low back pain and is available across the VA healthcare system; however, despite yoga being the most widely adopted of VHA's Complementary and Integrative Health (C...

What is the current status of trial NCT05103475?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2022-08-15. Estimated completion is 2023-10-31.

What interventions are being tested in trial NCT05103475?

The interventions under investigation include: Control (BEHAVIORAL), Rage Against the Pain (RAP) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05103475?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.